LONGMEN CAPITAL
Longmen Capital is a private equity firm focused on investing in the medical sector. The Shenzhen, Guangdong-headquartered firm was founded in 2017.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-10 | Kaidi Medical | Longmen Capital investment in Series A - Kaidi Medical | 100 M CNY |
| 2022-01-07 | Crystal Egg Bio | Longmen Capital investment in Seed Round - Crystal Egg Bio | N/A |
| 2021-12-23 | Qiyu Biotech | Longmen Capital investment in Series B - Qiyu Biotech | 200 M CNY |
| 2021-05-27 | Hopstem | Longmen Capital investment in Series A - Hopstem | N/A |
| 2021-03-29 | Chinagene Tech | Longmen Capital investment in Seed Round - Chinagene Tech | 70 M CNY |
| 2021-02-23 | Lyvgen Biopharma | Longmen Capital investment in Series C - Lyvgen Biopharma | 10 M USD |
| 2021-02-18 | Ractigen Therapeutics | Longmen Capital investment in Series A - Ractigen Therapeutics | 110 M CNY |
| 2021-02-07 | Prosit Sole Biotechnology | Longmen Capital investment in Series B - Prosit Sole Biotechnology | N/A |
| 2020-10-23 | Sirnaomics | Longmen Capital investment in Series D - Sirnaomics | 105 M USD |
| 2018-04-28 | LeapMed | Longmen Capital investment in Series B - LeapMed | 20 M CNY |